India Pharmaceuticals

Lyka Labs Ltd (LYKALABS)

Track

Lyka Labs Ltd witnessed six buy transactions by five insiders over the past ninety days, totaling 4,975,280 INR. These acquisitions involved promoters and affiliated groups, reflecting increased ownership stakes. No executive sales occurred during this period, while the stock price experienced an 11.2% gain, following the most recent February results.
Ticker: LYKALABS Exchange: NSI
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Lyka Labs Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.5
Kunal N Gandhi Promoter Large shareholder
Transaction date
Purchase
Price
430.93
Quantity 39,641
Value ₹1,012,490
2.5
Kunal N Gandhi Promoter Large shareholder
Transaction date
Purchase
Price
342.71
Quantity 7,960
Value ₹145,664
2.5
Nehal Gandhi Promoter Large shareholder
Transaction date
Purchase
Price
245.35
Quantity 87,498
Value ₹712,972
2.5
Kunal Gandhi Promoter Large shareholder
Transaction date
Purchase
Price
70.49
Quantity 6,533
Value ₹460,482
Enai Trading and Investment Pvt. Promoter Group Large shareholder
Transaction date
Purchase
Price
71.19
Quantity 11,312
Value ₹805,323
Alisha Gandhi Promoter Group Large shareholder
Transaction date
Purchase
Price
67.91
Quantity 5,000
Value ₹339,569
Ipca Laboratories Limited Large shareholder
Transaction date
Purchase
Price
139.50
Quantity 2,600,000
Value ₹362,700,000
2.5
Kunal Gandhi Director Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 1,350,000
Value ₹0
Narendra I. Gandhi HUF Large shareholder
Transaction date
Sale
Price
0.00
Quantity 1,350,000
Value ₹0
Ipca Laboratories Limited Large shareholder
Transaction date
Purchase
Price
139.50
Quantity 2,400,000
Value ₹334,800,000
Narendra Ishwarlal Gandhi Large shareholder
Transaction date
Sale
Price
0.00
Quantity 634,429
Value ₹0
Nehal Narendra Gandhi Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 634,429
Value ₹0
Narendra Ishwarlal Gandhi Large shareholder
Transaction date
Sale
Price
0.00
Quantity 148,000
Value ₹0
Nehal Narendra Gandhi Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 148,000
Value ₹0
Nehal Narendra Gandhi Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 385,200
Value ₹0
IPCA LABORATORIES LIMITED Large shareholder
Transaction date
Purchase
Price
139.50
Quantity 2,000,000
Value ₹279,000,000
Narendra I Gandhi HUF Large shareholder
Transaction date
Sale
Price
0.00
Quantity 50,776
Value ₹0
Kunal N Gandhi Director Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 50,776
Value ₹0
Ipca Laboratories Limited Large shareholder
Transaction date
Purchase
Price
130.50
Quantity 781
Value ₹101,921
ENAI TRADING AND INVESTMENT PRIVATE LIMITED Large shareholder
Transaction date
Purchase
Price
55.00
Quantity 550,000
Value ₹30,250,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-30 2026-06-29 B Purchase
2.5
Kunal N Gandhi

Promoter

Large shareholder
39,641
430.93
₹1,012,490 		39,641 430.93 ₹1,012,490
2026-06-30 2026-06-29 B Purchase
2.5
Kunal N Gandhi

Promoter

Large shareholder
7,960
342.71
₹145,664 		7,960 342.71 ₹145,664
2026-06-26 2026-06-25 B Purchase
2.5
Nehal Gandhi

Promoter

Large shareholder
87,498
245.35
₹712,972 		87,498 245.35 ₹712,972
2026-06-26 2026-06-25 B Purchase
2.5
Kunal Gandhi

Promoter

Large shareholder
6,533
70.49
₹460,482 		6,533 70.49 ₹460,482
2026-06-26 2026-06-24 B Purchase Enai Trading and Investment Pvt.

Promoter Group

Large shareholder
11,312
71.19
₹805,323 		11,312 71.19 ₹805,323
2026-06-26 2026-06-24 B Purchase
Alisha Gandhi

Promoter Group

Large shareholder
5,000
67.91
₹339,569 		5,000 67.91 ₹339,569
2024-04-17 2024-04-16 B Purchase Ipca Laboratories Limited Large shareholder
2,600,000
139.50
₹362,700,000 		2,600,000 139.50 ₹362,700,000
2023-06-28 2023-06-27 B Purchase
2.5
Kunal Gandhi
Director Large shareholder
1,350,000
0.00
₹0 		1,350,000 0.00 ₹0
2023-06-28 2023-06-27 S Sale Narendra I. Gandhi HUF Large shareholder
1,350,000
0.00
₹0 		1,350,000 0.00 ₹0
2023-04-20 2023-04-18 B Purchase Ipca Laboratories Limited Large shareholder
2,400,000
139.50
₹334,800,000 		2,400,000 139.50 ₹334,800,000
2023-04-03 2023-03-31 S Sale Narendra Ishwarlal Gandhi Large shareholder
634,429
0.00
₹0 		634,429 0.00 ₹0
2023-04-03 2023-03-31 B Purchase Nehal Narendra Gandhi Large shareholder
634,429
0.00
₹0 		634,429 0.00 ₹0
2023-03-31 2023-03-29 S Sale Narendra Ishwarlal Gandhi Large shareholder
148,000
0.00
₹0 		148,000 0.00 ₹0
2023-03-31 2023-03-29 B Purchase Nehal Narendra Gandhi Large shareholder
148,000
0.00
₹0 		148,000 0.00 ₹0
2023-03-22 2023-03-20 B Purchase Nehal Narendra Gandhi Large shareholder
385,200
0.00
₹0 		385,200 0.00 ₹0
2023-03-17 2023-03-15 B Purchase IPCA LABORATORIES LIMITED Large shareholder
2,000,000
139.50
₹279,000,000 		2,000,000 139.50 ₹279,000,000
2022-10-11 2022-10-04 S Sale Narendra I Gandhi HUF Large shareholder
50,776
0.00
₹0 		50,776 0.00 ₹0
2022-10-11 2022-10-04 B Purchase Kunal N Gandhi Director Large shareholder
50,776
0.00
₹0 		50,776 0.00 ₹0
2022-02-25 2022-02-23 B Purchase Ipca Laboratories Limited Large shareholder
781
130.50
₹101,921 		781 130.50 ₹101,921
2019-11-29 2019-08-09 B Purchase ENAI TRADING AND INVESTMENT PRIVATE LIMITED Large shareholder
550,000
55.00
₹30,250,000 		550,000 55.00 ₹30,250,000
Explore more

More insider trading research around Lyka Labs Ltd

More insider trades in India
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Asia-Pacific